The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters

Thrombosis Research

Volumn 124, Issue 1, 2009, Pages 132-136

  Tripodi, Armando ^a   Primignani, Massimo ^a   Chantarangkul, Veena ^a   Viscardi, Ylenia ^a   Dell'Era, Alessandra ^a   Fabris, Federica M ^a   Mannucci, Pier Mannuccio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Chronic liver disease; Liver transplantation; Prognosis

Indexed keywords

ANTITHROMBIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; BLOOD SAMPLING; CLINICAL STUDY; CORRELATION ANALYSIS; DEVICE; DISEASE SEVERITY; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; TECHNIQUE; THROMBOCYTE COUNT; THROMBOELASTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; THROMBELASTOGRAPHY;

EID: 64649094825     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.11.008     Document Type: Article

References (25)

1. Caprini J.A., Traverso C.I., and Arcelus J.I. Perspectives on thromboelastography. Sem Thromb Hemost 21 suppl 4 (1995) 91-93
2. Gilleis B.S. Thromboelastography and liver transplantation. Sem Thromb Hemost 21 suppl 4 (1995) 45-49
3. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transaction of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
4. Lang T., Bauters A., Braun S.L., Pötzsch B., von Pape K.W., Kolde H.J., et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 16 (2005) 301-310
5. Nielsen V.G., Geary B.T., and Baird M.S. Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. Anesth Analg 91 (2000) 35-39
6. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., et al. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor liver. Gastroenterology 124 (2003) 91-96
7. Hedner U., and Erhardtsen E. Hemostatic disorders in liver disease. In: Schiff E.R., Sorrell M.F., and Maddrey W.C. (Eds). Diseases of the Liver (2003), Lippincott Williams and Wilkins, Philadelphia 625-635
8. Hollestelle M.J., Geertzen H.G., Straatsburg I.H., van Gulik T.M., and van Mourik J.A. Factor VIII expression in liver disease. Thromb Haemost 91 (2004) 267-275
9. Lisman T., Bongers T.N., Adelmeijer J., Janssen H.L., de Maat M.P., de Groot P.G., et al. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 44 (2006) 53-61
10. Tripodi A., Salerno F., Chantarangkul V., Clerici M., Cazzaniga M., Primignani M., et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 41 (2005) 553-558
11. Tripodi A., Primignani M., Chantarangkul V., Clerici M., Dell'Era A., Fabris F., et al. Thrombin Generation in Patients with Cirrhosis: The Role of Platelets. Hepatology 44 (2006) 440-445
12. Dahlback B. Progress in the understanding of the protein C anticoagulant pathway. Int J Hematol 79 (2004) 109-116
13. Huntington J.A. Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J Thromb Haemost 1 (2003) 1535-1549
14. Tripodi A., Caldwell S.H., Hoffman M., Trotter J.F., and Sanyal A.J. The Prothrombin Time Test as a Measure of Bleeding Risk and Prognosis in Liver Disease. Aliment Pharmacol Ther 26 (2007) 141-148
15. Montalto P., Vlachogiannakos J., Cox D.J., Pastacaldi S., Patch D., and Burroughs A.K. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 37 (2002) 463-470
16. Ordinas A., Escolar G., Cirera I., Viñas M., Cobo F., Bosch J., et al. Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions. Hepatology 24 (1996) 1137-1142
17. Poordad F. Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther 26 suppl 1 (2007) 5-11
18. Chau T.N., Chan Y.W., Patch D., Tokunaga S., Greenslade L., and Burroughs A.K. Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut 43 (1998) 267-271
19. Ben-Ari Z., Panagou M., Patch D., Bates S., Osman E., Pasi J., et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thromboelastography. J Hepatol 26 (1997) 554-559
20. Trotter J.F., Brimhall B., Arjal R., and Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 10 (2004) 995-1000
21. Robert A., and Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio. Hepatology 24 (1996) 1392-1394
22. Kovacs M.J., Wong A., MacKinnon K., Weir K., Keeney M., Boyle E., et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost 71 (1994) 727-730
23. Denson K.W., Reed S.V., Haddon M.E., Woodhams B., Brucato C., and Ruiz J. Comparative Studies of Rabbit and Human Recombinant Tissue Factor Reagents. Thromb Res 94 (1999) 255-261
24. liver) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology 46 (2007) 520-527
25. Bellest L., Eschwege V., Poupon R., Chazouillères O., and Robert A. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology 46 (2007) 528-534